Stay updated on Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy and safety comparison of deucravacitinib to placebo in participants with moderate-to-severe scalp psoriasis in a Phase 3B/4 clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:58.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that participants must be men and women diagnosed with stable plaque psoriasis with scalp involvement for 6 months or more. Previously, no information was provided in this section.
    Difference
    15%
    Check dated 2024-05-22T20:55:20.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:26:09.000Z thumbnail image

Stay in the know with updates to Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page.